Glenmark receives USFDA approval for Derma Smoothe Topical oil

Glenmark Pharmaceuticals has received final USFDA approval for generic version of Derma-Smoothe Topical Oil, used in the treatment of scalp psoriasis. The topical oil is a generic version of Derma-Smoothe/FS Topical Oil, 0.01 per cent (scalp oil), of Hill Dermaceuticals, Inc and has a approximate market value of around USD 14 million per annum.

Company Profile : Glenmark Pharma Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.